Technical Analysis for GENE - Genetic Technologies Ltd

Grade Last Price % Change Price Change
grade F 2.19 6.83% 0.14
GENE closed up 6.83 percent on Wednesday, September 18, 2019, on 16 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical GENE trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Fell Below 20 DMA Bearish 6.83%
20 DMA Support Bullish 4.29%
50 DMA Resistance Bearish 0.46%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.46%
Pocket Pivot Bullish Swing Setup 0.46%
Doji - Bearish? Reversal 0.46%
Wide Bands Range Expansion 0.46%
Up 3 Days in a Row Strength 0.46%
Crossed Above 20 DMA Bullish 4.29%

Older signals for GENE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Genetic Technologies Limited provides genetic testing services. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine cancer; neurogenetic diagnostic assays; and gene testing for gene related disorders. The company also provides forensics tests, such as presumptive and confirmatory testing, individual DNA profiling, species identification, and animal forensic testing; paternity tests, which include antenatal, deceased estate, grandparent, immigration, legal paternity, non-legal paternity, sibling, twins, and Y-Chromosome DNA testing, as well as DNA profiling; and personal DNA testing comprising sports performance and ancestry gene testing. In addition, it offers animals' tests consisting of disease testing, breed identification, coat color, and forensic DNA testing, as well as DNA clinical services; and plant tests, including genomic and Xpress sequencing services. Further, the company is involved in the out-licensing of its intellectual property relating to non-coding DNA; and research and development activities in the areas of genetics and related fields. It operates in Australia, the United States, China, Canada, and Switzerland. The company was formerly known as Duketon Goldfields N.L. and changed it name to Genetic Technologies Limited in August 2000 as a result of the change in business from mining to biotechnology. Genetic Technologies Limited is headquartered in Fitzroy, Australia.
Biotechnology Cancer Biology Disease Breast Cancer Ovarian Cancer Genetics Medical Tests Applied Genetics DNA Clinical Services Genetic Testing DNA Paternity Testing
Is GENE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.32
52 Week Low 1.5601
Average Volume 81,774
200-Day Moving Average 2.9246
50-Day Moving Average 2.217
20-Day Moving Average 2.0619
10-Day Moving Average 2.0608
Average True Range 0.1875
ADX 18.16
+DI 26.5916
-DI 18.3479
Chandelier Exit (Long, 3 ATRs ) 2.2875
Chandelier Exit (Short, 3 ATRs ) 2.2885
Upper Bollinger Band 2.3203
Lower Bollinger Band 1.8035
Percent B (%b) 0.75
BandWidth 25.064261
MACD Line -0.0181
MACD Signal Line -0.0526
MACD Histogram 0.0345
Fundamentals Value
Market Cap 35.56 Million
Num Shares 16.2 Million
EPS -0.45
Price-to-Earnings (P/E) Ratio -4.87
Price-to-Sales 33.69
Price-to-Book 1.92
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.40
Resistance 3 (R3) 2.38 2.28 2.37
Resistance 2 (R2) 2.28 2.23 2.30 2.35
Resistance 1 (R1) 2.24 2.20 2.26 2.26 2.34
Pivot Point 2.14 2.14 2.16 2.16 2.14
Support 1 (S1) 2.10 2.09 2.12 2.12 2.04
Support 2 (S2) 2.00 2.06 2.02 2.03
Support 3 (S3) 1.96 2.00 2.02
Support 4 (S4) 1.98